All content on this site is intended for healthcare professionals only. By acknowledging this message and accessing the information on this website you are confirming that you are a Healthcare Professional. If you are a patient or carer, please visit the MDS Alliance
The use of whole-genome sequencing as an alternative diagnostic tool for cytogenetic analysis in myeloid cancers
The use of whole-genome sequencing as an alternative diagnostic tool for cytogenetic analysis in myeloid cancers.
What baseline factors affect QoL in MDS? How do these change with treatment?
During the 2021 ASCO Annual Meeting, the MDS Hub spoke with Mikkael A. Sekeres, Sylvester Comprehensive Cancer Center, Miami, US. We asked, What baseline factors affect...
"The MDS Hub allows you to access the most relevant updates in myelodysplastic syndromes and related disorders. We aim to deliver valuable and up-to-date information and expert opinions to all physicians practicing hemato-oncology."